BridgeMD
New treatment option for Fetal Growth Restriction
Official title Maternal Left Lateral Position in Fetal Growth Restriction
ClinicalTrials.gov ID: NCT06919692
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if maternal left-lateral positioning in pregnancy works to treat fetal growth restriction. This study will also help us learn about the effects of left-lateral positioning on maternal metabolomics, maternal mental health, fetal cardiac function, and delivery outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Pregnant persons between 18 - 65 years of age, with a diagnosis of fetal growth restriction, with an estimated fetal weight less than tenth percentile
- Participants with a singleton pregnancy between 24- and 34-weeks' gestational age
- Participants with fluency in English or Spanish language
You likely can't join if
- Patients with a known history of deep vein thrombosis, pulmonary embolism, or hypercoagulability disorder
- Patients with a pre-pregnancy BMI greater than 40
- Pregnancy with severe abnormality in umbilical artery Doppler flow, including absent end-diastolic flow (AEDF) and reverse end-diastolic flow (REDF)
- Patients receiving anticoagulation therapy
- Pregnancy with suspected chromosomal anomalies or a multifetal pregnancy
- Patients with an active smoking status during pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Aurora, Colorado, United States
- Denver, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aurora, Colorado, United States; Denver, Colorado, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.